MINDACT ADJUVANT PUBLICATIONS & ABSTRACTS
Clinical evidence from MINDACT

Evidence / Adjuvant / MINDACT
The EORTC 10041/BIG 03-04 MINDACT Trial is Feasible: Results of the Pilot Phase
PUBLICATION: European Journal of Cancer, December 2011, Volume 47, Issue 18, Pages 2742–2749. AUTHORS: Emiel Rutgers, Martine J. Piccart-Gebhart, Jan Bogaerts, Suzette Delaloge, Laura Van ‘t Veer, Isabel Teresa Rubio, Giuseppe Viale, Alastair M. Thompson, Rodolfo Passalacqua, Ulrike Nitz, Anita Vindevoghel, Jean-Yves Pierga, Peter M. Ravdin, Gustavo Werutsky, Fatima Cardoso Read More
Clinical Application of the 70-gene Profile: The MINDACT Trial
PUBLICATION: J Clin Oncol. 2008 Feb 10;26(5):729-35. doi: 10.1200/JCO.2007.14.3222. AUTHORS: Cardoso F., Van't Veer L., Rutgers E., Loi S., Mook S., Piccart-Gebhart M.J. SUMMARY: Its prospective validation is currently ongoing through the MINDACT (Microarray in Node-Negative Disease May Avoid Chemotherapy) trial, a 6,000-patient randomized, multicentric trial. This article reviews the Read More
Individualization of Therapy Using MammaPrint: from Development to the MINDACT Trial
PUBLICATION: Cancer Genomics & Proteomics. 2007 May-Jun;4(3):147-55. AUTHORS: Mook S., Van't Veer L.J., Rutgers E.J., Piccart-Gebhart M.J., Cardoso F. SUMMARY: A narrative review of the development and validation of MammaPrint. Read more: Mook et al_2007_Cancer Genomics & Proteomic_Individualization-of-Therapy


